November 9, 2025
Implement patient-reported outcomes (PROs) for patient-centered drug development
This course is designed for professionals involved in clinical research, regulatory affairs, and market access who seek to integrate patient-reported outcomes (PROs) into drug development programs. It provides a step-by-step guide to developing a robust PRO strategy that supports regulatory approval, reimbursement, and patient-centered value messaging.
Technical topics include:
Selection, evaluation, and validation of PRO instruments.
Psychometric testing, data capture, and interpretation of PRO data.
Regulatory and payer expectations for qualitative and quantitative PRO evidence.
Determining meaningful change and the need for new instruments.
This course includes tools and concepts that can be immediately applied, including:
Practical frameworks for reviewing and selecting PRO measures.
Real-world case studies highlighting successful PRO strategies and common pitfalls.
Interactive discussions on best practices for PRO implementation in clinical trials.
This short course is offered in-person at the ISPOR Europe 2024 conference.
*Conference attendance is not required to attend an ISPOR Short Course. Separate registration is required for conference attendees.
LEVEL: Experienced
TRACK: Patient-Centered Research
FACULTY MEMBERS
Bend, OR, USA
Schedule:
LENGTH: 4 Hours | Course runs 1 day
Sunday, 9 November 2025 | Course runs 1 Day
08:00-12:00 Central European Time (CET)
REGISTER HERE
*Conference attendance is not required to attend an ISPOR Short Course. Separate registration is required for conference attendees.
Visit the ISPOR Europe 2025 Program page to view all short courses offered.